Energy Metabolism and Mitochondrial Superoxide Anion Production in Pre-symptomatic Striatal Neurons Derived from Human-Induced Pluripotent Stem Cells Expressing Mutant Huntingtin
In the present study, we investigated whether mutant huntingtin (mHTT) impairs mitochondrial functions in human striatal neurons derived from induced pluripotent stem cells (iPSCs). Striatal neurons and astrocytes derived from iPSCs from unaffected individuals (Ctrl) and Huntington’s disease (HD) patients with HTT gene containing increased number of CAG repeats were used to assess the effect of mHTT on bioenergetics and mitochondrial superoxide anion production. The human neurons were thoroughly characterized and shown to express MAP2, DARPP32, GABA, synapsin, and PSD95. In human neurons and astrocytes expressing mHTT, the ratio of mHTT to wild-type huntingtin (HTT) was 1:1. The human neurons were excitable and could generate action potentials, confirming successful conversion of iPSCs into functional neurons. The neurons and astrocytes from Ctrl individuals and HD patients had similar levels of ADP and ATP and comparable respiratory and glycolytic activities. The mitochondrial mass, mitochondrial membrane potential, and superoxide anion production in human neurons appeared to be similar regardless of mHTT presence. The present results are in line with the results obtained in our previous studies with isolated brain mitochondria and cultured striatal neurons from YAC128 and R6/2 mice, in which we demonstrated that mutant huntingtin at early stages of HD pathology does not deteriorate mitochondrial functions. Overall, our results argue against bioenergetic deficits as a factor in HD pathogenesis and suggest that other detrimental processes might be more relevant to the development of HD pathology.
KeywordsHuntington’s disease Mitochondria Neurons Respiration Glycolysis Reactive oxygen species
Induced pluripotent stem cells
Human medium spiny neurons
Reactive oxygen species
Brain-derived neurotrophic factor
Glia-derived neurotrophic factor
Oxygen consumption rates
Extracellular acidification rates
Tetramethylrhodamine, methyl ester
Carbonyl cyanide p-trifluoromethoxyphenylhydrazone
Human embryonic stem cells
We are very thankful to Dr. George Daley (Harvard University, Cambridge, MA) and Dr. David Gamm (University of Wisconsin, Madison, WI) for providing human undifferentiated induced pluripotent stem cells.
This study was supported by National Institutes of Health grant R01 NS098772 and in part by a grant from Indiana Traumatic Spinal Cord & Brain Injury Research Fund to N.B.
Compliance with Ethical Standards
Conflict of Interests
The authors declare that they have no conflict of interests.
- 2.MacDonald ME, Ambrose CM, Duyao MP, Myers RH, Lin C, Srinidhi L, Barnes G, Taylor SA et al (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes. Cell 72(6):971–983Google Scholar
- 14.Shirendeb UP, Calkins MJ, Manczak M, Anekonda V, Dufour B, McBride JL, Mao P, Reddy PH (2012) Mutant huntingtin’s interaction with mitochondrial protein Drp1 impairs mitochondrial biogenesis and causes defective axonal transport and synaptic degeneration in Huntington’s disease. Hum Mol Genet 21(2):406–420PubMedGoogle Scholar
- 24.Ohlemacher SK, Iglesias CL, Sridhar A, Gamm DM, Meyer JS (2015) Generation of highly enriched populations of optic vesicle-like retinal cells from human pluripotent stem cells. Curr Protoc Stem Cell Biol 321H(8):1–1H.8.20Google Scholar
- 31.Zhang N, An MC, Montoro D, Ellerby LM (2010) Characterization of human Huntington’s disease cell model from induced pluripotent stem cells. PLoS Curr 2RRN1193Google Scholar
- 36.Camnasio S, Delli CA, Lombardo A, Grad I, Mariotti C, Castucci A, Rozell B, Lo RP et al (2012) The first reported generation of several induced pluripotent stem cell lines from homozygous and heterozygous Huntington’s disease patients demonstrates mutation related enhanced lysosomal activity. Neurobiol Dis 46(1):41–51PubMedGoogle Scholar
- 39.Kedaigle AJ, Fraenkel E, Atwal RS, Wu M, Gusella JF, MacDonald ME, Kaye JA, Finkbeiner S et al (2019) Bioenergetic deficits in Huntington’s disease iPSC-derived neural cells and rescue with glycolytic metabolites. Hum Mol Genet. https://doi.org/10.1093/hmg/ddy430
- 50.Perevoshchikova IV, Gerencser AA, Brand MD (2015) Lack of oxidative stress in a mouse neural cell stem cell model of Huntington’s disease. Free Radic Biol Med 87:S32Google Scholar
- 53.Xu X, Tay Y, Sim B, Yoon SI, Huang Y, Ooi J, Utami KH, Ziaei A et al (2017) Reversal of phenotypic abnormalities by CRISPR/Cas9-mediated gene correction in Huntington disease patient-derived induced pluripotent stem cells. Stem Cell Rep 8(3):619–633Google Scholar
- 55.Polyzos AA, Lee DY, Datta R, Hauser M, Budworth H, Holt A, Mihalik S, Goldschmidt P et al (2019) Metabolic reprogramming in astrocytes distinguishes region-specific neuronal susceptibility in Huntington mice. Cell Metab 291–216Google Scholar